In interviews at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference, researchers discussed the potential impact of ultra-high resolution brain positron emission tomography (PET) as well as emerging PET radiotracers for detecting coronary artery disease in obese patients and diagnosing clear cell renal cell carcinoma.
Can a new positron emission tomography (PET) agent enhance the diagnosis of clear cell renal cell carcinoma (ccRCC)? Could ultra-high resolution brain PET reinvent neuroimaging? Can an emerging PET radiotracer facilitate earlier detection of coronary artery disease (CAD) in obese patients?
Researchers considered these questions and more when discussing a few of the innovations emerging from research presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
Krishna Patel, MD discussed key advantages with 18F-flurpiridaz that may expand access to stress cardiac PET myocardial perfusion imaging and facilitate detection of CAD in obese patients.
In addition to higher sensitivity and specificity rates in comparison to the use of 99mTc-SPECT in obese patients, 18F-flurpiridaz offers unit dose availability and a longer half-life (110 minutes) than other PET perfusion tracer agents, according to Dr. Patel, director of cardiac PET at Mount Sinai Morningside in New York City.
Recent research revealed an 87 percent sensitivity rate and a 100 percent positive predictive value for positive scans with 89ZR-DFO-girentuximab in the diagnosis of ccRCC, pointed out Jeremie Calais, M.D., Ph.D., an associate professor at the Ahmanson Translational Theranostics Division of the Department of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA).
(Editor's note: To catch up on other innovations and research presented at the SNMMI 2023 conference, visit https://www.diagnosticimaging.com/conferences/snmmi .)
Roger Lecomte, Ph.D., emphasized that ultra-high resolution brain PET offers a level of characterization and quantification of brain regions significantly beyond that of whole-body PET.
“The spatial resolution is a factor of two better than HRRT (high resolution research tomograph) and a factor of three better than any clinical scanners today. It’s a quantum leap in terms of spatial resolution,” said Dr. Lecomte, a professor of nuclear medicine and radiobiology at the University of Sherbrooke in Quebec, Canada.
For more insights from Drs. Calais, Patel and Lecomte, watch the video below.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
Interventional Radiology Study Shows Low Breast Cancer Recurrence 16 Months After Cryoablation
March 29th 2024In a cohort of patients with invasive breast cancer and tumor sizes ranging between 0.3 to 9 cm, image-guided cryoablation was associated with a 10 percent recurrence rate at 16 months, according to research recently presented at the Society of Interventional Radiology (SIR) conference.
Emerging Insights on MRI-Guided Transurethral Ultrasound Ablation for Prostate Cancer
March 21st 2024For men with prostate cancer, the use of MRI-guided transurethral ultrasound ablation (TULSA) led to a 92 percent decrease in median prostate volume at one year, according to new research recently presented at Society of Interventional Radiology (SIR) conference.
Could Cloud-Based 'Progressive Loading' be a Boon for Radiology Workflows?
March 13th 2024The newly launched Progressive Loading feature, available through RamSoft’s OmegaAI software, reportedly offers radiologist rapid uploading of images that is faster than on-site networks and other cloud-based systems regardless of the network radiologists are using.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.